Project

Immune-modulatory radiotherapy to enhance the effects of neoadjuvant PD - L1 blockade after neoadjuvant chemotherapy in patients with resectable stage III ( N2) non -small cell lung cacner (NSCLC)

Ongoing - recruitment active · 2020 until 2030

Früh Martin, Hutter Franziska, Müller Fiona